Are Your State Legislators Taking Drug Lobbying Money Too?

Not only are Congressmen taking handouts from the mega-drug companies, so are your state legislators to the tune of more than $44 million in 2003 and 2004, according to an analysis by the Center for Public Integrity. That doesn't include another $8 million earmarked for various election campaigns...

Why drug companies invest so much on state legislators makes great sense, if you follow the money. Drug company revenues could drop as much as $4 billion by 2008 if states take advantage of their clout to push for price reductions.

The top five drug-related companies or organizations that spent the most lobbying your state in 2003-04:

  • Pharmaceutical Research and Manufacturers of America -- $4.5 million
  • Eli Lilly -- $4.3 million
  • GlaxoSmithKline -- $4.1 million
  • Pfizer -- $4 million
  • Johnson and Johnson -- $3.1 million

Here's the really disturbing part, folks: More than 40 percent of those dollars were directed at lobbying efforts in three states -- California, New York and Texas -- because their combined spending alone amounted to nearly 30 percent of the total spent nationwide on Medicaid drug purchases.

No wonder the drugs you may be paying for already cost too much. Reports like this one merely refuel my passion for replacing the existing, broken conventional health care paradigm, addicted to drug-based "cures," with one that emphasizes prevention and treats the real causes of disease.

Center for Public Integrity April 6, 2006 Free Full Text Report

Washington Post April 6, 2006

Post your comment
Click Here and be the first to comment on this article